US Stock MarketDetailed Quotes
OPTN OptiNose
- 0.530
- +0.050+10.33%
Close Nov 25 16:00 ET
- 0.544
- +0.015+2.76%
Post 16:15 ET
79.88MMarket Cap-1826P/E (TTM)
0.553High0.490Low1.72MVolume0.490Open0.480Pre Close916.04KTurnover2.06%Turnover RatioLossP/E (Static)150.83MShares2.10052wk High-1.95P/B44.35MFloat Cap0.32152wk Low--Dividend TTM83.75MShs Float30.000Historical High--Div YieldTTM13.19%Amplitude0.321Historical Low0.531Avg Price1Lot Size
About OptiNose Company
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Company Profile
SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees132
Fiscal Year Ends12-31
Address777 Township Line Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com
Company Executives
- Name
- Position
- Salary
- Dr. Ramy A. Mahmoud, M.D.
- Chief Executive Officer and Director
- 2.41M
- P. Terence Kohler, Jr
- Chief Financial Officer
- --
- Anthony J. Krick
- Vice President, Finance and Chief Accounting Officer
- --
- Michael F. Marino, III,
- Chief Legal Officer and Corporate Secretary
- 1.32M
- Paul Spence, Jr
- Chief Commercial Officer
- 664.02K
- R. John Fletcher
- Chairman of the Board
- 120.22K
- Wilhelmus C. M. Groenhuysen
- Independent Director
- 100.92K
- Dr. Eric Bednarski
- Independent Director
- 88.42K
- Kyle Dempsey
- Independent Director
- 90.92K
- Sandra L. Helton
- Independent Director
- 103.42K
- Tomas J. Heyman
- Independent Director
- 96.88K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
